PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
18 hedge funds and large institutions have $4.6M invested in PLx Pharma Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
88% more capital inflows, than outflows
Capital inflows: $79.1K | Capital outflows: $42.1K
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0.07% more ownership
Funds ownership: 22.25% → 22.32% (+0.07%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 19 → 18 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Heritage Way Advisors
Rockford,
Illinois
|
+$45.8K |
| 2 |
Renaissance Technologies
New York
|
+$19.6K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$6.82K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.58K |
| 5 |
Millennium Management
New York
|
+$3.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$27.2K |
| 2 |
Capital Wealth Alliance
Scottsdale,
Arizona
|
-$12K |
| 3 |
BlackRock
New York
|
-$1.36K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
| 5 |
Tower Research Capital (TRC)
New York
|
-$499 |
PLXP Hedge Fund Activity: Q1 2020 in Review
18 of the 4,549 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q1 2020, worth a combined $4.6M — down 48% from $8.9M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PLXP and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 5 added.
The largest buyer was Heritage Way Advisors, adding an estimated $45.8K. The largest seller was Wells Fargo, cutting an estimated $27.2K.
- 18 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q1 2020, down from 19 in Q4 2019.
- Funds reported $4.6M of PLx Pharma Inc. Common Stock stock for Q1 2020, down 48% quarter-over-quarter.
- 1 fund opened new PLx Pharma Inc. Common Stock positions in Q1 2020 and 2 closed out, a net change of -1 holder.
- The largest PLx Pharma Inc. Common Stock buyer in Q1 2020 was Heritage Way Advisors, an estimated $45.8K added.
- The largest PLx Pharma Inc. Common Stock seller in Q1 2020 was Wells Fargo, an estimated $27.2K sold.
Based on aggregated 13F filings for Q1 2020.